Reduced dose brentuximab vedotin for mycosis fungoides appears to prolong response duration by balancing efficacy and tolerability Meeting Abstract
| Authors: | Munayirji, B.; Khan, N.; Myskowski, P.; Geller, S.; Noor, S.; Kheterpal, M. K.; Davey, T.; Hancock, H.; Perez, L.; Miller, T.; Brutus, J.; Ganesan, N.; Chang, T.; Mangiaracina, G.; Patel, R.; Galasso, N.; Casper, E.; Ghione, P.; Stuver, R.; Epstein-Peterson, Z. D.; Pulitzer, M.; Khodadoust, M. S.; Kim, Y. H.; Horwitz, S. M.; Moskowitz, A. |
| Abstract Title: | Reduced dose brentuximab vedotin for mycosis fungoides appears to prolong response duration by balancing efficacy and tolerability |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 1702 |
| Language: | English |
| ACCESSION: | WOS:001159306706173 |
| DOI: | 10.1182/blood-2023-184898 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
